Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

US and British Researchers highlight distinct subtypes of myalgic encephalomyelitis

07.05.2008
US Researcher Announces Successful Antiviral Treatment For A Subset Of ME/CFS Patients

Researchers have identified distinct subtypes of myalgic encephalomyelitis (ME/CFS – also referred to as chronic fatigue syndrome) and there is renewed hope that treatments are available for this debilitating neurological illness.

One of these researchers is Dr A. Martin Lerner from Michigan, USA who will be revealing his ground breaking data from observations over the last seven years at the forthcoming International ME/CFS Conference 2008 in Westminster, London, on 23rd May.

Dr Lerner’s research indicates that specific long-term anti-herpesvirus pharmacokinetic administration of the drug valacyclovir/valganciclovir provides long-term significant benefit to one group of ME/CFS patients. Dr Lerner has identified two specific groups of patients; one with Herpesvirus Illness (EBV, HHV6, HCMV) with no co-infections and another Herpesvirus Illness with co-infections such as Lyme Disease, Babesiosis, Adult Rheumatic Fever and Mycoplasma Pneomoniae Myocarditis. Dr Lerner is the most experienced ME/CFS doctor in the world with long-term experience of treating an identified subset of patients with antivirals and has over twenty years of experience studying ME/CFS. He will be presenting his extensive data at the London conference, organised by the charity Invest in ME.

The theme of the conference is Sub Grouping of and Treatments for ME/CFS and the conference is changing the view that ME/CFS can be treated with a one-size-fits-all approach to treatment which the government and the National Institute for Clinical Excellence (NICE) have been advocating until now.

There is growing evidence of different subtypes and viral involvement in ME/CFS and the conference has aroused interest from the Chief Medical Officer and the UK Medical Research Council, both of which will be represented at the conference.

Other speakers at the conference include Dr Jonathan Kerr from St George’s University, London who has recently published a study identifying seven different genomic subtypes of ME/CFS and Dr John Chia, an infectious disease specialist from California, USA, who has is investigating antiviral treatments against enteroviruses as his recently published research showed that 135 out of 165 (82%) patients had stomach biopsy results that stained positive for enterovirus antigens compared with 7/ 34 (20%) of controls.

Dr Judy Mikovits, research director from the unique Whittemore Peterson Institute (WPI) in Nevada, USA will also be talking about the institute’s future plans for research and will be presenting data on a distinct subgroup of patients that is characterized by a significantly increased incidence of the development of Non-Hodgkins Lymphoma (NHL).

Myalgic Encephalomyelitis (ME/CFS) is defined by the World Health Organisation as a neurological illness (code WHO-ICD-10-G93.3). With an estimated 250,000 sufferers of ME/CFS in the UK alone, of which 60,000 (one quarter of the people) are severely affected, many of them children, the illness is thought to cost the UK economy over £6 billion per year. Little public funding of biomedical research is currently provided by the government.
The varying symptoms experienced by many severe ME/CFS sufferers may include: - post-exertional malaise, general chronic weakness of limbs, cognitive problems such as memory loss & concentration difficulties, severe headaches, problems with balance and fine motor control, muscle pain, light sensitivity, vocal/muscular limitations, hypersensitivity, sleep & temperature disturbance, cardiovascular symptoms, digestive disturbances, neurological disturbances.

In its most extreme form it can leave sufferers bedridden and can even be fatal.

It is hoped that the conference, bringing to an end ME Awareness Month, will kick-start publicly funded biomedical research into ME/CFS based on a more relevant and scientific approach to diagnosis and treatment of the illness.

Details of the CPD accredited conference may be found at – www.investinme.org

Kathleen McCall | alfa
Further information:
http://www.investinme.org

More articles from Health and Medicine:

nachricht Inhaling air pollution-like irritant alters defensive heart-lung reflex for hypertension
19.06.2019 | University of South Florida (USF Innovation)

nachricht Nitric oxide-scavenging hydrogel developed for rheumatoid arthritis treatment
06.06.2019 | Pohang University of Science & Technology (POSTECH)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Successfully Tested in Praxis: Bidirectional Sensor Technology Optimizes Laser Material Deposition

The quality of additively manufactured components depends not only on the manufacturing process, but also on the inline process control. The process control ensures a reliable coating process because it detects deviations from the target geometry immediately. At LASER World of PHOTONICS 2019, the Fraunhofer Institute for Laser Technology ILT will be demonstrating how well bi-directional sensor technology can already be used for Laser Material Deposition (LMD) in combination with commercial optics at booth A2.431.

Fraunhofer ILT has been developing optical sensor technology specifically for production measurement technology for around 10 years. In particular, its »bd-1«...

Im Focus: The hidden structure of the periodic system

The well-known representation of chemical elements is just one example of how objects can be arranged and classified

The periodic table of elements that most chemistry books depict is only one special case. This tabular overview of the chemical elements, which goes back to...

Im Focus: MPSD team discovers light-induced ferroelectricity in strontium titanate

Light can be used not only to measure materials’ properties, but also to change them. Especially interesting are those cases in which the function of a material can be modified, such as its ability to conduct electricity or to store information in its magnetic state. A team led by Andrea Cavalleri from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg used terahertz frequency light pulses to transform a non-ferroelectric material into a ferroelectric one.

Ferroelectricity is a state in which the constituent lattice “looks” in one specific direction, forming a macroscopic electrical polarisation. The ability to...

Im Focus: Determining the Earth’s gravity field more accurately than ever before

Researchers at TU Graz calculate the most accurate gravity field determination of the Earth using 1.16 billion satellite measurements. This yields valuable knowledge for climate research.

The Earth’s gravity fluctuates from place to place. Geodesists use this phenomenon to observe geodynamic and climatological processes. Using...

Im Focus: Tube anemone has the largest animal mitochondrial genome ever sequenced

Discovery by Brazilian and US researchers could change the classification of two species, which appear more akin to jellyfish than was thought.

The tube anemone Isarachnanthus nocturnus is only 15 cm long but has the largest mitochondrial genome of any animal sequenced to date, with 80,923 base pairs....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

 
Latest News

A new force for optical tweezers awakens

19.06.2019 | Physics and Astronomy

New AI system manages road infrastructure via Google Street View

19.06.2019 | Information Technology

A new manufacturing process for aluminum alloys

19.06.2019 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>